サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428364

創薬技術の世界市場レポート 2024

Drug Discovery Technologies Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創薬技術の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

創薬技術の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.4%の年間複合成長率（CAGR）で1,083億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、遺伝子編集へのCRISPRの採用、精密医療アプローチの拡大、創薬におけるオミクス技術の応用、創薬における量子コンピューティングの利用、および患者の増加に起因すると考えられます。派生異種移植片（PDX）モデル。予測期間の主な動向には、ハイスループットスクリーニングの進歩、自動実験装置の開発、学術研究と企業調査の連携、イメージングと顕微鏡の技術進歩、創薬における人工知能の統合、3D細胞培養技術、医薬品設計における機械学習の導入、製薬会社とテクノロジー新興企業とのコラボレーション、データセキュリティのためのブロックチェーンの統合などです。

急性疾患および慢性疾患の有病率の増加が予想されており、将来創薬技術市場を牽引する態勢が整っています。慢性疾患は1年以上持続し、継続的な治療が必要ですが、創薬技術と医薬品開発の進歩により、数多くの革新的な治療法が誕生してきました。デジタルヘルスツール、人工知能（AI）、機械学習などの新興テクノロジーを医薬品の研究開発（R&D）プロセスに組み込むことで、重要な障壁を克服し、流行している慢性疾患の臨床試験を合理化する機会が生まれます。国連（UN）によると、2023年 5月の時点で、米国の死亡者10人中7人は慢性疾患が原因であり、年間死亡者数は170万人を超えています。したがって、急性および慢性疾患の蔓延は創薬技術市場の原動力となると予想されます。

ヘルスケア費の増加により、創薬技術市場の成長が促進されると予想されます。ヘルスケア費には、健康に重点を置いた医療サービス、家族計画活動、栄養プログラム、緊急援助の提供に関連するすべての費用が含まれます。ヘルスケア支出の急増により研究開発が支援され、先進技術やインフラストラクチャへの資金提供を通じて創薬技術の拡大が促進されます。たとえば、メディケア・メディケイド・サービスセンターが2023年12月に報告したところによると、米国のヘルスケア支出は2022年に4.1％増加し、4兆5,000億米ドル（1人当たり1万3,493ドル）に達し、国内総生産の17.3％を占めました。したがって、ヘルスケア支出の増加は、創薬技術市場の成長の重要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の創薬技術市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ハイスループットスクリーニング
  • ゲノミクス
  • ナノテクノロジー
  • バイオインフォマティクス
  • 化合物化学
  • 薬理ゲノミクス
  • バイオチップ
  • 生物分析機器
  • リボ核酸インターフェース（RNAI）
  • 世界の創薬技術市場、医薬品タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 低分子薬
  • 生物学的製剤
  • 世界の創薬技術市場、疾患用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • がん疾患
  • 免疫疾患
  • 神経疾患
  • 心血管疾患
  • その他の疾患用途
  • 世界の創薬技術市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社
  • バイオ医薬品企業
  • バイオテクノロジー企業
  • 研究機関
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の創薬技術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の創薬技術市場、国別、実績および予測、2018年から2023年、2023年から2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 創薬技術市場の競合情勢
  • 創薬技術市場の企業プロファイル
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Thermo Fisher Scientific Inc.
    • AstraZeneca plc.
    • Merck KGaA

第31章 その他の大手および革新的な企業

  • GE HealthCare Technologies Inc.
  • Agilent Technologies Inc.
  • Dassault Systemes SA
  • Charles River Laboratories International Inc.
  • Bio-Rad Laboratories Inc.
  • Evotec SE
  • Curia Global Inc.
  • Aragen Life Sciences Private Limited
  • Luminex Corporation
  • BioXcel Therapeutics Inc.
  • Certara Inc.
  • Schrodinger Inc.
  • Sygnature Discovery Ltd.
  • Recursion Pharmaceuticals Inc.
  • InSilico Medicine Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14209

Drug discovery technology encompasses a range of techniques and strategies employed in the identification of new drugs and the recognition of chemical entities with potential therapeutic applications. These methodologies are geared towards pinpointing and developing potential drug candidates for the treatment of various diseases.

The primary categories of drug discovery technologies include high-throughput screening, genomics, nanotechnology, bioinformatics, combinational chemistry, pharmacogenomics, biochips, bioanalytical instruments, and ribonucleic acid interface (RNAI). High-throughput screening is a method designed to rapidly assess the biological activity of numerous samples, expediting the drug discovery process. These technologies find application in the discovery of drug types such as small molecule drugs and biologic drugs, addressing conditions such as cancer, immunological disorders, neurological ailments, cardiovascular diseases, and others. Pharmaceutical companies, biopharmaceutical companies, biotechnology firms, research institutes, and other entities utilize these technologies for drug discovery purposes.

The drug discovery technologies research report is one of a series of new reports from The Business Research Company that provides drug discovery technologies market statistics, including the drug discovery technologies global market size, regional shares, competitors with a drug discovery technologies market share, detailed drug discovery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery technologies. This drug discovery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug discovery technologies market size has grown rapidly in recent years. It will grow from $66.08 billion in 2023 to $72.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to the expansion of genomic and proteomic research, heightened comprehension of molecular biology, the growth of combinatorial chemistry, the adoption of bioinformatics and computational approaches, and the emergence of targeted therapies.

The drug discovery technologies market size is expected to see rapid growth in the next few years. It will grow to $108.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to the adoption of CRISPR for gene editing, the expansion of precision medicine approaches, the application of omics technologies in drug development, the utilization of quantum computing in drug discovery, and the rise of patient-derived xenograft (PDX) models. Key trends in the forecast period include advancements in high-throughput screening, the development of automated laboratory equipment, collaboration between academic and industry research, technological advances in imaging and microscopy, the integration of artificial intelligence in drug discovery, 3D cell culture technologies, the adoption of machine learning in drug design, collaboration between pharmaceutical companies and tech startups, and the integration of blockchain for data security.

The anticipated increase in the prevalence of acute and chronic diseases is poised to drive the drug discovery technologies market in the future. Chronic diseases, which persist for a year or more and necessitate ongoing medical attention, have witnessed numerous innovative treatments through advancements in drug discovery technologies and drug development. The incorporation of emerging technologies such as digital health tools, artificial intelligence (AI), and machine learning in the drug research and development (R&D) process presents opportunities to overcome critical barriers and streamline clinical trials for prevalent chronic diseases. As of May 2023, according to The United Nations (UN), chronic diseases accounted for seven out of 10 deaths in the US, resulting in over 1.7 million annual fatalities. Hence, the escalating prevalence of acute and chronic diseases is expected to be a driving force for the drug discovery technologies market.

The increase in healthcare expenditures is anticipated to propel the growth of the drug discovery technologies market. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. A surge in healthcare spending supports research and development, fostering the expansion of drug discovery technologies through the funding of advanced technologies and infrastructure. For instance, in December 2023, as reported by the Centers for Medicare & Medicaid Services, US healthcare spending witnessed a 4.1% increase in 2022, reaching $4.5 trillion, or $13,493 per person, constituting 17.3% of the country's gross domestic product. Consequently, the rise in healthcare expenditures is a significant driver for the growth of the drug discovery technologies market.

The emergence of advanced technologies stands out as a prominent trend in the drug discovery technologies market. Major companies in this sector are actively introducing sophisticated technologies to maintain their market positions. In May 2023, Google LLC, a US-based technology company, unveiled the Target and Lead Identification Suite-an AI-based tool designed to expedite drug discovery. This tool aids businesses in anticipating and understanding protein structure, a critical element in drug research, by assisting researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data. The Suite is anticipated to save considerable time and money in the drug development process, addressing a longstanding challenge in the biopharmaceutical sector.

Major companies operating in the drug discovery technologies market are concentrating on advanced solutions, such as drug research and development platforms, to enhance precision in high-throughput analysis. A drug research and development platform serve as a systematic framework for discovering, designing, testing, and bringing pharmaceutical compounds to market. For example, in July 2023, Dotmatics Inc., a US-based scientific software company focused on research and development, launched the Small Molecule Drug Discovery Solution. This comprehensive platform, equipped with pre-configured workflows and enhanced data management features, aims to foster collaboration, boost productivity, streamline operations, and expedite the transformation of data into actionable insights. This advancement accelerates the development of life-enhancing drug therapies by providing researchers with targeted capabilities and templates for a cohesive workspace spanning hit discovery to lead optimization research.

In August 2021, Bayer AG, a Germany-based pharmaceutical company, completed the acquisition of Vividion Therapeutics for approximately $1.5 billion. This strategic move is intended to provide Bayer with novel approaches for small-molecule drug discovery and access to advanced drug discovery programs focused on inhibitors and activators. Vividion Therapeutics, a US-based biotechnology company, is dedicated to discovering and developing selective small molecule medicines targeting traditionally inaccessible disease targets.

Major companies operating in the drug discovery technologies market report are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Dassault Systemes SA, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrodinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.

North America was the largest region in the drug discovery technologies market in 2023. The regions covered in the drug discovery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug discovery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The drug discovery technologies market consists of revenues earned by entities by drug screening, predictive analytics, modeling, simulation, and computational capabilities. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery technologies market also includes sales of automation tools, computational chemistry software, imaging software, and mass spectrometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Technologies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: High Throughput Screening; Genomics; Nanotechnology; Bioinformatics; Combinational Chemistry; Pharmacogenomics; Biochips; Bioanalytical Instruments; Ribonucleic Acid Interface (RNAI)
  • 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
  • 3) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
  • 4) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
  • Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc.; Merck KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Discovery Technologies Market Characteristics

3. Drug Discovery Technologies Market Trends And Strategies

4. Drug Discovery Technologies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Discovery Technologies Market Size and Growth

  • 5.1. Global Drug Discovery Technologies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Discovery Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Discovery Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Discovery Technologies Market Segmentation

  • 6.1. Global Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High Throughput Screening
  • Genomics
  • Nanotechnology
  • Bioinformatics
  • Combinational Chemistry
  • Pharmacogenomics
  • Biochips
  • Bioanalytical Instruments
  • Ribonucleic Acid Interface (RNAI)
  • 6.2. Global Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule Drugs
  • Biologic Drugs
  • 6.3. Global Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Diseases
  • Immunological Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Other Disease Applications
  • 6.4. Global Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Other End-Users

7. Drug Discovery Technologies Market Regional And Country Analysis

  • 7.1. Global Drug Discovery Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Discovery Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Discovery Technologies Market

  • 8.1. Asia-Pacific Drug Discovery Technologies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Discovery Technologies Market

  • 9.1. China Drug Discovery Technologies Market Overview
  • 9.2. China Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Discovery Technologies Market

  • 10.1. India Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Discovery Technologies Market

  • 11.1. Japan Drug Discovery Technologies Market Overview
  • 11.2. Japan Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Discovery Technologies Market

  • 12.1. Australia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Discovery Technologies Market

  • 13.1. Indonesia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Discovery Technologies Market

  • 14.1. South Korea Drug Discovery Technologies Market Overview
  • 14.2. South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Discovery Technologies Market

  • 15.1. Western Europe Drug Discovery Technologies Market Overview
  • 15.2. Western Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Discovery Technologies Market

  • 16.1. UK Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Discovery Technologies Market

  • 17.1. Germany Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Discovery Technologies Market

  • 18.1. France Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Discovery Technologies Market

  • 19.1. Italy Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Discovery Technologies Market

  • 20.1. Spain Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Discovery Technologies Market

  • 21.1. Eastern Europe Drug Discovery Technologies Market Overview
  • 21.2. Eastern Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Discovery Technologies Market

  • 22.1. Russia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Discovery Technologies Market

  • 23.1. North America Drug Discovery Technologies Market Overview
  • 23.2. North America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Discovery Technologies Market

  • 24.1. USA Drug Discovery Technologies Market Overview
  • 24.2. USA Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Discovery Technologies Market

  • 25.1. Canada Drug Discovery Technologies Market Overview
  • 25.2. Canada Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Discovery Technologies Market

  • 26.1. South America Drug Discovery Technologies Market Overview
  • 26.2. South America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Discovery Technologies Market

  • 27.1. Brazil Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Discovery Technologies Market

  • 28.1. Middle East Drug Discovery Technologies Market Overview
  • 28.2. Middle East Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Discovery Technologies Market

  • 29.1. Africa Drug Discovery Technologies Market Overview
  • 29.2. Africa Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Discovery Technologies Market Competitive Landscape And Company Profiles

  • 30.1. Drug Discovery Technologies Market Competitive Landscape
  • 30.2. Drug Discovery Technologies Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca plc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Merck KGaA
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Discovery Technologies Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc.
  • 31.2. Agilent Technologies Inc.
  • 31.3. Dassault Systemes SA
  • 31.4. Charles River Laboratories International Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Evotec SE
  • 31.7. Curia Global Inc.
  • 31.8. Aragen Life Sciences Private Limited
  • 31.9. Luminex Corporation
  • 31.10. BioXcel Therapeutics Inc.
  • 31.11. Certara Inc.
  • 31.12. Schrodinger Inc.
  • 31.13. Sygnature Discovery Ltd.
  • 31.14. Recursion Pharmaceuticals Inc.
  • 31.15. InSilico Medicine Inc.

32. Global Drug Discovery Technologies Market Competitive Benchmarking

33. Global Drug Discovery Technologies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Discovery Technologies Market

35. Drug Discovery Technologies Market Future Outlook and Potential Analysis

  • 35.1 Drug Discovery Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Discovery Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Discovery Technologies Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer